<DOC>
	<DOCNO>NCT01020877</DOCNO>
	<brief_summary>The primary object study evaluate relative bioavailability test formulation metronidazole vaginal gel already market reference formulation MetroGel-Vaginal Gel® healthy adult female subject .</brief_summary>
	<brief_title>Bioavailability Metronidazole Vaginal Gel Healthy Subjects</brief_title>
	<detailed_description>Criteria Evaluation : FDA Bioequivalence Criteria Statistical Methods : FDA Bioequivalence Statistical Methods</detailed_description>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Females , 18 year age old . Good health determine lack clinically significant abnormality health assessment perform screen . Signed informed consent form , meet criteria current FDA regulation . If female child bear potential prepared abstain sexual intercourse use reliable method contraception study ( e.g . condom , IUD , oral implant hormonal contraceptive ) . Weight within + 25 % normal height weight body frame describe Novum Standard Operating Procedures adapt `` MetLife® Height Weight Tablets '' , Copyright© 1993 . Females pregnant , lactating , likely become pregnant study . History allergy sensitivity metronidazole , history drug hypersensitivity intolerance , opinion Investigator , would compromise safety subject study . Significant history current evidence chronic infectious disease , system disorder organ disorder . History psychiatric disorder occur within last two year require hospitalization medication . Presence medical condition require regular treatment prescription drug ( contraceptive hormonal replacement therapy ) . Use pharmacologic agent know significantly induce inhibit drugmetabolizing enzyme within 30 day prior dose . Receipt drug part research study within 30 day prior dose . Drug alcohol addiction require treatment past 12 month . Donation significant loss whole blood ( 480 mL ) within 30 day plasma within 14 day prior dose . Positive test HIV , Hepatitis B surface antigen Hepatitis C antibody . Positive test result drug abuse screen . Evidence vulvovaginitis cervicitis ( e.g . Bacterial vaginosis , vaginal candidiasis , Trichomonas vaginalis , Chlamydia trachomatis , Neisseria gonorrhea , history Herpes simplex human papillomavirus ) . Vulvar vaginal condition may affect absorption drug . Clinically significant abnormal finding PAP smear within previous 12 month .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Healthy Subjects</keyword>
	<keyword>Healthy , Normal Subjects</keyword>
</DOC>